Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 5, 2015, Pages 2901-2903

  Mandelbrot, Laurent ^a,b,c   Duro, Dominique ^a   Belissa, Emilie ^d   Peytavin, Gilles ^d,e  

^a HÔPITAL LOUIS MOURIER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^d BICHAT HOSPITAL   (France)

^e UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RILPIVIRINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; BLOOD PLACENTA BARRIER; CONCENTRATION AT STEADY-STATE; DRUG ABSORPTION; DRUG CLEARANCE; EFFECTIVE CONCENTRATION; EX VIVO STUDY; HUMAN; LIMIT OF QUANTITATION; PLACENTA PERFUSION; PLACENTAL TRANSFER; PREGNANT WOMAN; PRIORITY JOURNAL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; FETOMATERNAL TRANSFUSION; METABOLISM; PLACENTA; PREGNANCY;

FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE INHIBITORS; RILPIVIRINE;

EID: 84931281646     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00075-15     Document Type: Article

References (21)

1. Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L. 2008. Mother-tochild HIV transmission despite antiretroviral therapy in the ANRS French perinatal cohort. AIDS 22:289-299. http://dx.doi.org/10.1097/QAD.0b013e3282f3d63c.
2. Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Rouzioux C, Perilhou A, Warszawski J, Blanche S. 2015. No perinatal transmission of HIV-1 in women efficiently treated since conception, abstr 867. Abstr CROI 2015, Seattle, WA, 23 to 26 February 2015.
3. Morlat P. 2013. Prise en charge médicale des personnes vivant avec le VIH. Recommandations du groupe d'experts rapport 2013. Ministère des affaires sociales et de la Santé, Paris, France. http://www.sante.gouv.fr/IMG/pdf/Rapport-Morlat-2013-Mise-en-ligne.pdf.
4. US Department of Health and Human Services. 2015. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. US Department of Health and Human Services, Washington, DC. http://aidsinfo.nih.gov/contentfiles/lvguidelines/Peri-Recommendations.pdf.
5. Colbers A, Gingelmaier A, van der Ende M, Rijnders B, Burger D. 2014. Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy: two cases. AIDS 28:288-290. http://dx.doi.org/10.1097/QAD.0000000000000100.
6. Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. 2011. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr 57:290-296. http://dx.doi.org/10.1097/QAI.0b013e318221c56a.
7. Gavard L, Beghin D, Forestier F, Cayre Y, Peytavin G, Mandelbrot L, Farinotti R, Gil S. 2009. Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir. Eur J Obstet Gynecol Reprod Biol 147:157-160. http://dx.doi.org/10.1016/j.ejogrb.2009.08.007.
8. Myllynen P, Vahakangas K. 2013. Placental transfer and metabolism: an overview of the experimental models utilizing human placental tissue. Toxicol In Vitro 27:507-512. http://dx.doi.org/10.1016/j.tiv.2012.08.027.
9. Schneider H, Panigel M, Dancis J. 1972. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 114:822-828.
10. Forestier F, de Renty P, Peytavin G, Dohin E, Farinotti R, Mandelbrot L. 2001. Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. Am J Obstet Gynecol 185:178-181. http://dx.doi.org/10.1067/mob.2001.113319.
11. Vinot C, Gavard L, Treluyer JM, Manceau S, Courbon E, Scherrmann JM, Decleves X, Duro D, Peytavin G, Mandelbrot L, Giraud C. 2013. Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression. Antimicrob Agents Chemother 57:1415-1420. http://dx.doi.org/10.1128/AAC.01821-12.
12. Legardeur H, Girard G, Journy N, Ressencourt V, Durand-Zaleski I, Mandelbrot L. 2014. Factors predictive of macrosomia in pregnancies with a positive oral glucose challenge test: importance of fasting plasma glucose. Diabetes Metab 40:43-48. http://dx.doi.org/10.1016/j.diabet.2013.01.008.
13. Challier JC, D'Athis P, Guerre-Millo M, Nandakumaran M. 1983. Flow-dependent transfer of antipyrine in the human placenta in vitro. Reprod Nutr Dev 23:41-50. http://dx.doi.org/10.1051/rnd:19830104.
14. Jung BH, Rezk NL, Bridges AS, Corbett AH, Kashuba AD. 2007. Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 21:1095-1104. http://dx.doi.org/10.1002/bmc.865.
15. Janssen Products. 2011. Edurant highlights of prescribing information. Janssen Products, Titusville, NJ.
16. Benaboud S, Ekouevi DK, Urien S, Rey E, Arrive E, Blanche S, Gray G, Sim KL, Avit D, McIntyre J, Nerrienet E, Dabis F, Treluyer JM, Hirt D. 2011. Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates. Antimicrob Agents Chemother 55:331-337. http://dx.doi.org/10.1128/AAC.00631-10.
17. Calcagno A, Trentini L, Marinaro L, Montrucchio C, D'Avolio A, Ghisetti V, Di Perri G, Bonora S. 2013. Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy. J Antimicrob Chemother 68:1938-1939. http://dx.doi.org/10.1093/jac/dkt095.
18. Mandelbrot L, Duro D, Belissa E, Peytavin G. 2014. Placental transfer of darunavir in an ex vivo human cotyledon perfusion model. Antimicrob Agents Chemother 58:5617-5620. http://dx.doi.org/10.1128/AAC.03184-14.
19. Gavard L, Gil S, Peytavin G, Ceccaldi PF, Ferreira C, Farinotti R, Mandelbrot L. 2006. Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model. Am J Obstet Gynecol 195:296-301. http://dx.doi.org/10.1016/j.ajog.2006.01.017.
20. Else LJ, Taylor S, Back DJ, Khoo SH. 2011. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid). Antivir Ther 16:1139-1147. http://dx.doi.org/10.3851/IMP1918.
21. Ceccaldi PF, Ferreira C, Gavard L, Gil S, Peytavin G, Mandelbrot L. 2008. Placental transfer of enfuvirtide in the ex vivo human placenta perfusion model. Am J Obstet Gynecol 198:433.e431-433.e432. http://dx.doi.org/10.1016/j.ajog.2007.10.802.